First Command Advisory Services’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.55K Hold
9
﹤0.01% 971
2025
Q4
$1.79K Buy
+9
New +$1.63K ﹤0.01% 661
2023
Q1
Sell
-8
Closed 115
2022
Q4
$0 Buy
+8
New +$1.75K ﹤0.01% 73

Other funds holding CRL

First Command Advisory Services's CRL Position: Q1 2026 in Review

First Command Advisory Services held its Charles River Laboratories (CRL) position steady in Q1 2026 at 9 shares worth $1.55K. The position accounts for ﹤0.01% of the portfolio, ranked #971.

First Command Advisory Services first reported a position in CRL in Q4 2022 and has held it in 3 quarters since. The position peaked at $1.79K in Q4 2025. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • First Command Advisory Services held 9 shares of Charles River Laboratories worth $1.55K as of Q1 2026.
  • First Command Advisory Services left its Charles River Laboratories share count unchanged in Q1 2026.
  • Charles River Laboratories made up ﹤0.01% of First Command Advisory Services's portfolio in Q1 2026, its #971 holding.
  • First Command Advisory Services first reported a position in Charles River Laboratories in Q4 2022 and has held it in 3 quarters since.
  • First Command Advisory Services's Charles River Laboratories position peaked at $1.79K in Q4 2025.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on First Command Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.